Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 58 entries
Sorted by: Best Match Show Resources per page
Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction.

JACC. Basic to translational science

Aukrust P, Kleveland O, Gullestad L.
PMID: 34102669
JACC Basic Transl Sci. 2021 May 24;6(5):444-446. doi: 10.1016/j.jacbts.2021.01.007. eCollection 2021 May.

No abstract available.

Cite
Aukrust P, Kleveland O, Gullestad L. Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction. JACC Basic Transl Sci. 2021;6(5):444-446doi: 10.1016/j.jacbts.2021.01.007.
Aukrust, P., Kleveland, O., & Gullestad, L. (2021). Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction. JACC. Basic to translational science, 6(5), 444-446. https://doi.org/10.1016/j.jacbts.2021.01.007
Aukrust, Pål, et al. "Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction." JACC. Basic to translational science vol. 6,5 (2021): 444-446. doi: https://doi.org/10.1016/j.jacbts.2021.01.007
Aukrust P, Kleveland O, Gullestad L. Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction. JACC Basic Transl Sci. 2021 May 24;6(5):444-446. doi: 10.1016/j.jacbts.2021.01.007. eCollection 2021 May. PMID: 34102669; PMCID: PMC8165105.
Copy Download .nbib Format: NLM
Author's response to: letter to the editor.

Heart failure reviews

Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE.
PMID: 30043131
Heart Fail Rev. 2018 Sep;23(5):819. doi: 10.1007/s10741-018-9728-6.

No abstract available.

Cite
Ofstad AP, Atar D, Gullestad L, et al. Author's response to: letter to the editor. Heart Fail Rev. 2018;23(5):819doi: 10.1007/s10741-018-9728-6.
Ofstad, A. P., Atar, D., Gullestad, L., Langslet, G., & Johansen, O. E. (2018). Author's response to: letter to the editor. Heart failure reviews, 23(5), 819. https://doi.org/10.1007/s10741-018-9728-6
Ofstad, Anne Pernille, et al. "Author's response to: letter to the editor." Heart failure reviews vol. 23,5 (2018): 819. doi: https://doi.org/10.1007/s10741-018-9728-6
Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE. Author's response to: letter to the editor. Heart Fail Rev. 2018 Sep;23(5):819. doi: 10.1007/s10741-018-9728-6. PMID: 30043131.
Copy Download .nbib Format: NLM
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.

European heart journal

Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF.
PMID: 34665224
Eur Heart J. 2021 Dec 21;42(48):4918-4929. doi: 10.1093/eurheartj/ehab568.

AIMS: We evaluated the long-term prognostic value of invasively assessing coronary physiology after heart transplantation in a large multicentre registry.METHODS AND RESULTS: Comprehensive intracoronary physiology assessment measuring fractional flow reserve (FFR), the index of microcirculatory resistance (IMR), and coronary...

Cite
Ahn JM, Zimmermann FM, Arora S, et al. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021;42(48):4918-4929doi: 10.1093/eurheartj/ehab568.
Ahn, J. M., Zimmermann, F. M., Arora, S., Solberg, O. G., Angerås, O., Rolid, K., Rafique, M., Aaberge, L., Karason, K., Okada, K., Luikart, H., Khush, K. K., Honda, Y., Pijls, N. H. J., Lee, S. E., Kim, J. J., Park, S. J., Gullestad, L., & Fearon, W. F. (2021). Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. European heart journal, 42(48), 4918-4929. https://doi.org/10.1093/eurheartj/ehab568
Ahn, Jung-Min, et al. "Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation." European heart journal vol. 42,48 (2021): 4918-4929. doi: https://doi.org/10.1093/eurheartj/ehab568
Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021 Dec 21;42(48):4918-4929. doi: 10.1093/eurheartj/ehab568. PMID: 34665224; PMCID: PMC8691805.
Copy Download .nbib Format: NLM
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.

European heart journal

Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF.
PMID: 34665224
Eur Heart J. 2021 Dec 21;42(48):4918-4929. doi: 10.1093/eurheartj/ehab568.

AIMS: We evaluated the long-term prognostic value of invasively assessing coronary physiology after heart transplantation in a large multicentre registry.METHODS AND RESULTS: Comprehensive intracoronary physiology assessment measuring fractional flow reserve (FFR), the index of microcirculatory resistance (IMR), and coronary...

Cite
Ahn JM, Zimmermann FM, Arora S, et al. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021;42(48):4918-4929doi: 10.1093/eurheartj/ehab568.
Ahn, J. M., Zimmermann, F. M., Arora, S., Solberg, O. G., Angerås, O., Rolid, K., Rafique, M., Aaberge, L., Karason, K., Okada, K., Luikart, H., Khush, K. K., Honda, Y., Pijls, N. H. J., Lee, S. E., Kim, J. J., Park, S. J., Gullestad, L., & Fearon, W. F. (2021). Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. European heart journal, 42(48), 4918-4929. https://doi.org/10.1093/eurheartj/ehab568
Ahn, Jung-Min, et al. "Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation." European heart journal vol. 42,48 (2021): 4918-4929. doi: https://doi.org/10.1093/eurheartj/ehab568
Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021 Dec 21;42(48):4918-4929. doi: 10.1093/eurheartj/ehab568. PMID: 34665224.
Copy Download .nbib Format: NLM
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy.

Clinical transplantation

Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K.
PMID: 34747048
Clin Transplant. 2021 Nov 07;e14488. doi: 10.1111/ctr.14488. Epub 2021 Nov 07.

Cardiac allograft vasculopathy (CAV) remains a leading cause of long-term mortality after heart transplantation. Both preventive measures and treatment options are limited. This study aimed to evaluate the short-term effects of high-intensity interval training (HIT) on CAV in de...

Cite
Rafique M, Solberg OG, Gullestad L, et al. A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clin Transplant. 2021;e14488doi: 10.1111/ctr.14488.
Rafique, M., Solberg, O. G., Gullestad, L., Bendz, B., Holm, N. R., Neghabat, O., Dijkstra, J., Nytrøen, K., Rolid, K., & Lunde, K. (2021). A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clinical transplantation, e14488. https://doi.org/10.1111/ctr.14488
Rafique, Muzammil, et al. "A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy." Clinical transplantation vol. (2021): e14488. doi: https://doi.org/10.1111/ctr.14488
Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K. A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clin Transplant. 2021 Nov 07;e14488. doi: 10.1111/ctr.14488. Epub 2021 Nov 07. PMID: 34747048.
Copy Download .nbib Format: NLM
Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site.

Journal of plastic surgery and hand surgery

Gullestad HP, Ryder T, Goscinski M.
PMID: 34878354
J Plast Surg Hand Surg. 2021 Dec 08;1-6. doi: 10.1080/2000656X.2021.2010739. Epub 2021 Dec 08.

Although the vast majority of melanomas have a primary site, 3%-4% of all melanomas in distant sites display no known primary site (MUP). This phenomenon is not fully understood and various hypotheses have been introduced. The prognostic significance of...

Cite
Gullestad HP, Ryder T, Goscinski M. Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site. J Plast Surg Hand Surg. 2021;1-6doi: 10.1080/2000656X.2021.2010739.
Gullestad, H. P., Ryder, T., & Goscinski, M. (2021). Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site. Journal of plastic surgery and hand surgery, 1-6. https://doi.org/10.1080/2000656X.2021.2010739
Gullestad, Hans Petter, et al. "Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site." Journal of plastic surgery and hand surgery vol. (2021): 1-6. doi: https://doi.org/10.1080/2000656X.2021.2010739
Gullestad HP, Ryder T, Goscinski M. Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site. J Plast Surg Hand Surg. 2021 Dec 08;1-6. doi: 10.1080/2000656X.2021.2010739. Epub 2021 Dec 08. PMID: 34878354.
Copy Download .nbib Format: NLM
Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.

Journal of the American College of Cardiology

Broch K, Anstensrud AK, Woxholt S, Andersen GØ, Gullestad L.
PMID: 34353542
J Am Coll Cardiol. 2021 Aug 10;78(6):637-638. doi: 10.1016/j.jacc.2021.06.005.

No abstract available.

Cite
Broch K, Anstensrud AK, Woxholt S, et al. Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial. J Am Coll Cardiol. 2021;78(6):637-638doi: 10.1016/j.jacc.2021.06.005.
Broch, K., Anstensrud, A. K., Woxholt, S., Andersen, G. �. �., & Gullestad, L. (2021). Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial. Journal of the American College of Cardiology, 78(6), 637-638. https://doi.org/10.1016/j.jacc.2021.06.005
Broch, Kaspar, et al. "Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial." Journal of the American College of Cardiology vol. 78,6 (2021): 637-638. doi: https://doi.org/10.1016/j.jacc.2021.06.005
Broch K, Anstensrud AK, Woxholt S, Andersen GØ, Gullestad L. Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial. J Am Coll Cardiol. 2021 Aug 10;78(6):637-638. doi: 10.1016/j.jacc.2021.06.005. PMID: 34353542.
Copy Download .nbib Format: NLM
Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site.

Journal of plastic surgery and hand surgery

Gullestad HP, Ryder T, Goscinski M.
PMID: 34878354
J Plast Surg Hand Surg. 2021 Dec 08;1-6. doi: 10.1080/2000656X.2021.2010739. Epub 2021 Dec 08.

Although the vast majority of melanomas have a primary site, 3%-4% of all melanomas in distant sites display no known primary site (MUP). This phenomenon is not fully understood and various hypotheses have been introduced. The prognostic significance of...

Cite
Gullestad HP, Ryder T, Goscinski M. Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site. J Plast Surg Hand Surg. 2021;1-6doi: 10.1080/2000656X.2021.2010739.
Gullestad, H. P., Ryder, T., & Goscinski, M. (2021). Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site. Journal of plastic surgery and hand surgery, 1-6. https://doi.org/10.1080/2000656X.2021.2010739
Gullestad, Hans Petter, et al. "Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site." Journal of plastic surgery and hand surgery vol. (2021): 1-6. doi: https://doi.org/10.1080/2000656X.2021.2010739
Gullestad HP, Ryder T, Goscinski M. Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site. J Plast Surg Hand Surg. 2021 Dec 08;1-6. doi: 10.1080/2000656X.2021.2010739. Epub 2021 Dec 08. PMID: 34878354.
Copy Download .nbib Format: NLM
Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation.

Journal of the American College of Cardiology

Ahn JM, Zimmermann FM, Gullestad L, Angerås O, Karason K, Russell K, Lunde K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Solberg OG, Fearon WF.
PMID: 34886963
J Am Coll Cardiol. 2021 Dec 14;78(24):2425-2435. doi: 10.1016/j.jacc.2021.10.009.

BACKGROUND: Single-center data suggest that the index of microcirculatory resistance (IMR) measured early after heart transplantation predicts subsequent acute rejection.OBJECTIVES: The goal of this study was to validate whether IMR measured early after transplantation can predict subsequent acute rejection...

Cite
Ahn JM, Zimmermann FM, Gullestad L, et al. Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation. J Am Coll Cardiol. 2021;78(24):2425-2435doi: 10.1016/j.jacc.2021.10.009.
Ahn, J. M., Zimmermann, F. M., Gullestad, L., Angerås, O., Karason, K., Russell, K., Lunde, K., Okada, K., Luikart, H., Khush, K. K., Honda, Y., Pijls, N. H. J., Lee, S. E., Kim, J. J., Park, S. J., Solberg, O. G., & Fearon, W. F. (2021). Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation. Journal of the American College of Cardiology, 78(24), 2425-2435. https://doi.org/10.1016/j.jacc.2021.10.009
Ahn, Jung-Min, et al. "Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation." Journal of the American College of Cardiology vol. 78,24 (2021): 2425-2435. doi: https://doi.org/10.1016/j.jacc.2021.10.009
Ahn JM, Zimmermann FM, Gullestad L, Angerås O, Karason K, Russell K, Lunde K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Solberg OG, Fearon WF. Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation. J Am Coll Cardiol. 2021 Dec 14;78(24):2425-2435. doi: 10.1016/j.jacc.2021.10.009. PMID: 34886963.
Copy Download .nbib Format: NLM
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial.

EBioMedicine

Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K.
PMID: 34329947
EBioMedicine. 2021 Aug;70:103511. doi: 10.1016/j.ebiom.2021.103511. Epub 2021 Jul 28.

BACKGROUND: The gut microbiota represents a potential treatment target in heart failure (HF) through microbial metabolites such as trimethylamine N-oxide (TMAO) and systemic inflammation. Treatment with the probiotic yeast Saccharomyces boulardii have been suggested to improve left ventricular ejection...

Cite
Awoyemi A, Mayerhofer C, Felix AS, et al. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine. 2021;70:103511doi: 10.1016/j.ebiom.2021.103511.
Awoyemi, A., Mayerhofer, C., Felix, A. S., Hov, J. R., Moscavitch, S. D., Lappegård, K. T., Hovland, A., Halvorsen, S., Halvorsen, B., Gregersen, I., Svardal, A., Berge, R. K., Hansen, S. H., Götz, A., Holm, K., Aukrust, P., Åkra, S., Seljeflot, I., Solheim, S., Lorenzo, A., Gullestad, L., Trøseid, M., & Broch, K. (2021). Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine, 70103511. https://doi.org/10.1016/j.ebiom.2021.103511
Awoyemi, Ayodeji, et al. "Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial." EBioMedicine vol. 70 (2021): 103511. doi: https://doi.org/10.1016/j.ebiom.2021.103511
Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine. 2021 Aug;70:103511. doi: 10.1016/j.ebiom.2021.103511. Epub 2021 Jul 28. PMID: 34329947; PMCID: PMC8339250.
Copy Download .nbib Format: NLM
Transcriptional repression is epigenetically marked by H3K9 methylation during SV40 replication.

Clinical epigenetics

Kallestad L, Christensen K, Woods E, Milavetz B.
PMID: 25395994
Clin Epigenetics. 2014 Oct 27;6(1):21. doi: 10.1186/1868-7083-6-21. eCollection 2014.

BACKGROUND: We have recently shown that T-antigen binding to Site I results in the replication-dependent introduction of H3K9me1 into SV40 chromatin late in infection. Since H3K9me2 and H3K9me3 are also present late in infection, we determined whether their presence...

Cite
Kallestad L, Christensen K, Woods E, et al. Transcriptional repression is epigenetically marked by H3K9 methylation during SV40 replication. Clin Epigenetics. 2014;6(1):21doi: 10.1186/1868-7083-6-21.
Kallestad, L., Christensen, K., Woods, E., & Milavetz, B. (2014). Transcriptional repression is epigenetically marked by H3K9 methylation during SV40 replication. Clinical epigenetics, 6(1), 21. https://doi.org/10.1186/1868-7083-6-21
Kallestad, Les, et al. "Transcriptional repression is epigenetically marked by H3K9 methylation during SV40 replication." Clinical epigenetics vol. 6,1 (2014): 21. doi: https://doi.org/10.1186/1868-7083-6-21
Kallestad L, Christensen K, Woods E, Milavetz B. Transcriptional repression is epigenetically marked by H3K9 methylation during SV40 replication. Clin Epigenetics. 2014 Oct 27;6(1):21. doi: 10.1186/1868-7083-6-21. eCollection 2014. PMID: 25395994; PMCID: PMC4230732.
Copy Download .nbib Format: NLM
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy.

Clinical transplantation

Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K.
PMID: 34747048
Clin Transplant. 2022 Jan;36(1):e14488. doi: 10.1111/ctr.14488. Epub 2021 Dec 13.

Cardiac allograft vasculopathy (CAV) remains a leading cause of long-term mortality after heart transplantation. Both preventive measures and treatment options are limited. This study aimed to evaluate the short-term effects of high-intensity interval training (HIT) on CAV in de...

Cite
Rafique M, Solberg OG, Gullestad L, et al. A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clin Transplant. 2021;36(1):e14488doi: 10.1111/ctr.14488.
Rafique, M., Solberg, O. G., Gullestad, L., Bendz, B., Holm, N. R., Neghabat, O., Dijkstra, J., Nytrøen, K., Rolid, K., & Lunde, K. (2022). A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clinical transplantation, 36(1), e14488. https://doi.org/10.1111/ctr.14488
Rafique, Muzammil, et al. "A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy." Clinical transplantation vol. 36,1 (2022): e14488. doi: https://doi.org/10.1111/ctr.14488
Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K. A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clin Transplant. 2022 Jan;36(1):e14488. doi: 10.1111/ctr.14488. Epub 2021 Dec 13. PMID: 34747048.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 58 entries